Development partners
Searching for pipeline?
MondoTwin works with pharma, biotech, foundations, investors, and public funders looking for clinical-stage rare-disease programs. We find them in the evidence, construct them to be licensable, and support the transaction. Mandates are scoped individually.
- 01
Programs from our own pipeline, available under confidentiality.
- 02
Targeted searches on mandate, across the world’s clinical evidence and the research hosted on MondoTwin.
- 03
Assets constructed in the partner’s name and supported to signature.
Tell us what you are looking for
Therapeutic area, stage, modality, deal type, geography. A short note is enough; we will come back to you to scope the conversation.
Rare diseases have waited long enough.
Let's build what moves them forward.
